New Frontiers in Schizophrenia Treatment: Beyond Dopamine

New Frontiers in Schizophrenia Treatment Beyond Dopamine  Check out our extensive video library (see channel for our latest videos) Abstract For more than six decades, the treatment of schizophrenia has been dominated by dopamine-blocking antipsychotic medications. While this approach has transformed the management of psychotic symptoms such as

Antipsychotic Injectable Medications Deplete Neurotrophic Factor In Schizophrenia Patients

Antipsychotic Injectable Medications Deplete Neurotrophic Factor In Schizophrenia Patients Overview Schizophrenia (SCZ) and schizoaffective disorder (SAD) are severe psychiatric conditions influenced by both genetic and environmental factors. Serum brain-derived neurotrophic factor (BDNF) has been identified as a potential biomarker for these disorders, though its temporal changes remain unclear. This study analyzes data

New Frontiers in Schizophrenia Treatment: Beyond Dopamine